Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence
about
Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice.Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment optionsA review of anti-inflammatory agents for symptoms of schizophreniaCelecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsTargeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stressA Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia.TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model.The NMDA receptor as a target for cognitive enhancementAllopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits.Neurosteroids are endogenous neuroprotectants in an ex vivo glaucoma model.The role of oestrogen and other hormones in the pathophysiology and treatment of schizophreniaPregnenolone sulfate as a modulator of synaptic plasticity.Neurosteroids, stress and depression: potential therapeutic opportunities.Association between the CYP11 family and six cancer types.The neuroactive steroid pregnenolone sulfate stimulates trafficking of functional N-methyl D-aspartate receptors to the cell surface via a noncanonical, G protein, and Ca2+-dependent mechanism.Neuroactive Steroids in First-Episode Psychosis: A Role for Progesterone?NPAS3 Regulates Transcription and Expression of VGF: Implications for Neurogenesis and Psychiatric Disorders.Chiropractic Management of a Patient With Chronic Fatigue: A Case ReportSpecial biological issues in the management of women with schizophrenia.Progesterone and its metabolites as therapeutic targets in psychiatric disorders.Development of novel therapy of schizophrenia in children and adolescents.Investigational drugs for anxiety in patients with schizophrenia.New drug developments in psychosis: Challenges, opportunities and strategies.Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.New Targets for Schizophrenia Treatment beyond the Dopamine HypothesisPregnenolone, a cholesterol metabolite, induces glioma cell apoptosis via activating extrinsic and intrinsic apoptotic pathways5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients.Milestones on Steroids and the Nervous System: 10 years of basic and translational research.Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia.Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.Metal-Free Route for the Synthesis of 4-Acyl-1,2,3-Triazoles from Readily Available Building Blocks.Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex.
P2860
Q21133801-4498E7A0-B71C-4A85-9EBF-333687163B82Q22241447-0C591AF1-9CCD-48DF-9C75-7D225F0EC19CQ22241827-56D298CD-1167-4FEB-8F9C-D2A9EC287B11Q26741541-61C29055-9A87-4471-B10E-9EB6B9585F98Q30371274-2464F9FE-AF9A-4888-BD8B-87A0C538E9B7Q33624417-CC705D02-0505-46CF-A0C2-395140456004Q33807216-A48ABDFA-B472-4A8F-A9C8-5C3E6A955926Q34288139-1F500C28-60FC-4C13-B4A7-8D901CDFB855Q34324221-D324232C-DD7E-4EB6-AA5C-A4015E084AA0Q34789708-F9269A37-1CF1-4FDE-BC28-E513BE33005AQ36168609-93C5F0C9-6466-4CED-B172-B5E02498CFBDQ36224315-995D252F-356E-4DA4-887A-CDEBC0F2FBA4Q36666746-865185B4-418A-4BE5-A71F-86D86F65DB5DQ37001517-28754296-A8CC-4BB3-887A-5EEA97269C8CQ37027057-B8F54933-475B-4858-97FD-3282227710B0Q37322690-7146CE6A-549D-4CBE-940F-3CA8E2A2E893Q37399106-75F63D26-3E7D-481C-92B0-0083C72D49AEQ37410083-A71C6E72-1AB6-40A0-95EB-AFB7EFAD1B21Q38031287-2A7A50E0-9906-407C-AFEA-4EB675FA83E5Q38198091-C76E4601-4C35-4FD8-9191-C875C16F0AD6Q38223714-758EE302-4920-4741-BCCC-6FE6B4D8DA40Q38271298-0E22C7CE-DAA2-4493-B486-931A8EFF2F72Q38926246-78F0D4AB-3B5E-45BA-B531-018B9FE8C45DQ39428788-F5E9F737-1DDD-40BD-B39D-A4E8FD335EFFQ41573540-5E927784-8ABD-43B3-9083-42285B6CABE7Q42720269-92F38041-D81E-449B-B8D5-9C6C34B298A5Q47877573-1F7E81D0-8A71-4BA6-B367-A81C9D42E5A6Q48514095-C65C7C33-705F-44BF-8F6C-017051DC079FQ50046796-4416FB60-8915-4DF6-B722-E0F5101CE25BQ50632749-B59D2034-A820-4E7A-AF19-BEC678557453Q50853737-429959E6-63EF-4C4C-BE35-143FCFC8014BQ52139053-CA6B8321-73AE-4F98-AD0A-96344E2DEF23
P2860
Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pregnenolone as a novel therap ...... clinical and clinical evidence
@ast
Pregnenolone as a novel therap ...... clinical and clinical evidence
@en
Pregnenolone as a novel therap ...... clinical and clinical evidence
@nl
type
label
Pregnenolone as a novel therap ...... clinical and clinical evidence
@ast
Pregnenolone as a novel therap ...... clinical and clinical evidence
@en
Pregnenolone as a novel therap ...... clinical and clinical evidence
@nl
prefLabel
Pregnenolone as a novel therap ...... clinical and clinical evidence
@ast
Pregnenolone as a novel therap ...... clinical and clinical evidence
@en
Pregnenolone as a novel therap ...... clinical and clinical evidence
@nl
P2093
P3181
P1433
P1476
Pregnenolone as a novel therap ...... clinical and clinical evidence
@en
P2093
D W Bradford
J A Lieberman
J C Naylor
J L Strauss
P3181
P356
10.1016/J.NEUROSCIENCE.2011.06.076
P407
P577
2011-09-15T00:00:00Z